BSE filing, NSE: ORCHASP. Summary written from the filing by ALFA Finder's alert engine.
Orchasp Ltd: key numbers
- Share price
- ₹1.23
- Market cap
- ₹39.30 Cr
- Revenue (annual)
- ₹21.26 Cr
- Net profit (annual)
- ₹1.05 Cr
- P/E (TTM)
- 49.8×Sector 23.0×
- Promoter holding
- 18.48%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Orchasp Ltd
All →Orchasp Preferential Issue
Orchasp Limited clarified a drafting error in its AGM notice regarding the proposed preferential issue, correctly identifying the allottee as non-promoter rather than promoter group.
Orchasp Annual General Meeting
Orchasp Limited published the voting results for its 32nd Annual General Meeting held on September 30, 2026. All seven resolutions, including a preferential issue, were successfully passed.
Orchasp Annual General Meeting
Orchasp Ltd issued a corrigendum to its 32nd Annual General Meeting notice originally dated August 31, 2026, modifying details concerning its proposed preferential issue.
Orchasp Annual Report
Orchasp Limited has filed its 32nd Annual Report for the financial year 2025-26. This submission complies with the SEBI Listing Regulations.
Orchasp Annual General Meeting
Orchasp Limited issued a notice for its 32nd Annual General Meeting on 30-Sep-2026. The agenda includes the issuance of 1.5 crore equity shares for Rs. 7.11 Crore.
- Value
- ₹7.11 Cr
Orchasp Annual General Meeting
Orchasp Limited has scheduled its 32nd Annual General Meeting for September 30, 2026, through video conferencing. The cut-off date for e-voting is September 23, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.